Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study
暂无分享,去创建一个
P. Jones | M. Albertella | P. Loadman | C. Twelves | A. Lalani | C. Alcock | R. Phillips | A. Anthoney | P. Harris | E. Vjaters | R. Rampling | C. Dunk | A. Wong | N. Burnet